These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16044390)

  • 41. Papillomavirus and HPV typing.
    de Villiers EM
    Clin Dermatol; 1997; 15(2):199-206. PubMed ID: 9167904
    [No Abstract]   [Full Text] [Related]  

  • 42. Developments in L2-based human papillomavirus (HPV) vaccines.
    Schellenbacher C; Roden RBS; Kirnbauer R
    Virus Res; 2017 Mar; 231():166-175. PubMed ID: 27889616
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human Papillomavirus Infection and Vaccination.
    Valentino K; Poronsky CB
    J Pediatr Nurs; 2016; 31(2):e155-66. PubMed ID: 26586310
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cervical Cancer Screening and Prevention in 78 Sexually Transmitted Disease Clinics-United States, 2014-2015.
    McGinnis E; Meyerson BE; Meites E; Saraiya M; Griesse R; Snoek E; Haderxhanaj L; Markowitz LE; Smith W
    Sex Transm Dis; 2017 Oct; 44(10):637-641. PubMed ID: 28876317
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association of infections with human immunodeficiency virus and human papillomavirus in Honduras.
    Ferrera A; Melchers WJ; Velema JP; Figueroa M
    Am J Trop Med Hyg; 1997 Aug; 57(2):138-41. PubMed ID: 9288804
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence of human papillomavirus among STD clinic attenders in Jamaica: association of younger age and increased sexual activity.
    Figueroa JP; Ward E; Luthi TE; Vermund SH; Brathwaite AR; Burk RD
    Sex Transm Dis; 1995; 22(2):114-8. PubMed ID: 7624812
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence of human papillomavirus infection and its correlation with cervical lesions in commercial-sex workers in Japan.
    Ishi K; Suzuki F; Saito A; Kubota T
    J Obstet Gynaecol Res; 2000 Aug; 26(4):253-7. PubMed ID: 11049234
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human papillomavirus vaccines: a warty problem.
    Galloway DA
    Infect Agents Dis; 1994 Aug; 3(4):187-93. PubMed ID: 7827787
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine.
    Goldie SJ; Grima D; Kohli M; Wright TC; Weinstein M; Franco E
    Int J Cancer; 2003 Oct; 106(6):896-904. PubMed ID: 12918067
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human Papilloma Virus infection in sexually active adolescent girls.
    Michala L; Argyri E; Tsimplaki E; Tsitsika A; Bakoula C; Antsaklis A; Panotopoulou E
    Gynecol Oncol; 2012 Aug; 126(2):207-10. PubMed ID: 22561405
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sexually Transmitted Infections: A Novel Screening Strategy for Improving Women's Health in Vulnerable Populations.
    Frati ER; Fasoli E; Martinelli M; Colzani D; Bianchi S; Carnelli L; Amendola A; Olivani P; Tanzi E
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28632191
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epidemiology and natural history of genital human papillomavirus infection.
    Weaver BA
    J Am Osteopath Assoc; 2006 Mar; 106(3 Suppl 1):S2-8. PubMed ID: 16729554
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human papillomavirus: HPV information for clinicians.
    Centers for Disease Control and Prevention
    Ala Nurse; 2008 Dec-2009 Feb; 35(4):17-9. PubMed ID: 19166076
    [No Abstract]   [Full Text] [Related]  

  • 54. [Human papillomavirus prophylactic vaccines: stakes and perspectives].
    Hantz S; Alain S; Denis F
    Gynecol Obstet Fertil; 2006; 34(7-8):647-55. PubMed ID: 16807045
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vaccination as a prevention strategy for human papillomavirus-related diseases.
    Kahn JA
    J Adolesc Health; 2005 Dec; 37(6 Suppl):S10-6. PubMed ID: 16310136
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Variation in genital human papillomavirus infection prevalence and vaccination coverage among men and women in the USA.
    Han JJ; Tarney CM; Song J
    Future Oncol; 2017 Jun; 13(13):1129-1132. PubMed ID: 28589730
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
    Monsonego J; Zerat L; Syrjänen K; Zerat JC; Smith JS; Halfon P
    Vaccine; 2012 Jul; 30(35):5215-21. PubMed ID: 22713720
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HPV infection in women: psychosexual impact of genital warts and intraepithelial lesions.
    Graziottin A; Serafini A
    J Sex Med; 2009 Mar; 6(3):633-45. PubMed ID: 19170869
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia.
    Bosch FX; Burchell AN; Schiffman M; Giuliano AR; de Sanjose S; Bruni L; Tortolero-Luna G; Kjaer SK; Muñoz N
    Vaccine; 2008 Aug; 26 Suppl 10():K1-16. PubMed ID: 18847553
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genital human papillomavirus infection among patients attending an STD clinic.
    Strand A; Rylander E; Evander M; Wadell G
    Genitourin Med; 1993 Dec; 69(6):446-9. PubMed ID: 8282298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.